Native valve endocarditis vs Prosthetic valve endocarditis
How to tell Native valve endocarditis and Prosthetic valve endocarditis apart when a board question makes them look alike.
Step 2 CK pairs are in open beta while clinical review finishes. Spot an issue? Tell us.
Presence of prosthetic valve material is the immediate branch point that changes empiric regimen to include prosthetic-valve coverage.
Side by side
Infective endocarditis on a native valve without prosthetic material is managed with empiric coverage targeting methicillin-resistant staphylococci, streptococci, and enterococci.
Endocarditis involving prosthetic valve material, especially within 12 months of surgery, needs broader empiric therapy including biofilm-active coverage.
Vegetations on native valve tissue arise from endothelial injury and bloodstream seeding.
Prosthetic material supports biofilm formation with higher risk of resistant staphylococcal infection and periannular spread.
Before antibiotics, draw 3 blood-culture sets and perform echocardiography; native-valve empiric regimens commonly include vancomycin plus ceftriaxone while awaiting cultures.
Prosthetic-valve infection often has persistent bacteremia and may show paravalvular abscess or dehiscence on transesophageal echo; early cases often need vancomycin-based multidrug therapy with rifampin and gentamicin per protocol.
The trap
A major error is using native-valve empiric therapy for prosthetic-valve infection and missing resistant biofilm organisms. The resolving clue is any prosthetic valve history, especially recent implantation.
The repair move
Next best step: obtain 3 blood-culture sets, start prosthetic-valve empiric therapy such as IV vancomycin plus gentamicin plus rifampin according to local protocol, and request urgent infectious disease and cardiac surgery evaluation. Narrow regimen once susceptibilities return and monitor for conduction abnormalities or heart failure.
Try a free question
CoreA patient with bioprosthetic mitral valve placed 6 months ago presents with persistent bacteremia and new conduction delay. What is the next best step in management?
Show answer and explanation
Answer: A. Start prosthetic-valve empiric endocarditis regimen and obtain urgent surgical consultation. Prosthetic-valve endocarditis has high complication risk and requires immediate broad empiric therapy with early surgical involvement.
Why the other choices are tempting
- B. Wrong because native-valve regimens can be inadequate for prosthetic biofilm pathogens.
- C. Wrong because delaying therapy increases morbidity from invasive infection.
- D. Wrong because oral monotherapy is inappropriate for severe prosthetic-valve infection.
- E. Wrong because temporary hemodynamic improvement does not resolve invasive endocarditis risk.
Flashcards
Tap a card to flip it.
What single historical feature immediately changes empiric endocarditis therapy selection?
A prosthetic valve history changes therapy to prosthetic-valve endocarditis coverage.
Why is rifampin often included in prosthetic valve endocarditis regimens?
Rifampin has activity against biofilm-associated organisms on prosthetic material when used in combination.
Quick answers
What is the fastest way to tell Native valve endocarditis from Prosthetic valve endocarditis?
Presence of prosthetic valve material is the immediate branch point that changes empiric regimen to include prosthetic-valve coverage.
What is the key clue for Native valve endocarditis?
Infective endocarditis on a native valve without prosthetic material is managed with empiric coverage targeting methicillin-resistant staphylococci, streptococci, and enterococci.
What is the key clue for Prosthetic valve endocarditis?
Endocarditis involving prosthetic valve material, especially within 12 months of surgery, needs broader empiric therapy including biofilm-active coverage.
What is the common trap with Native valve endocarditis vs Prosthetic valve endocarditis?
A major error is using native-valve empiric therapy for prosthetic-valve infection and missing resistant biofilm organisms. The resolving clue is any prosthetic valve history, especially recent implantation.